Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China flag China · Delayed Price · Currency is CNY
23.75
-0.45 (-1.86%)
At close: Nov 17, 2026

SHA:688443 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
800.95230.730.071.070.48-
Other Revenue
0.030.030.030.15-39.19
800.98230.7330.091.210.4839.19
Revenue Growth
255.73%666.66%2384.11%154.92%-98.79%3502.99%
Cost of Revenue
119.4816.595.92-0.241.7719.67
Gross Profit
681.5214.1424.171.45-1.319.52
Selling, General & Admin
428.21319252.49173.79153.6224.22
Research & Development
457.18472.83609.79620.4454.49295.32
Other Operating Expenses
38.334.943.272.561.31.84
Operating Expenses
927.46797.25866.19796.74609.42321.34
Operating Income
-245.96-583.11-842.02-795.29-610.72-301.82
Interest Expense
-24.85-31.41-28.9-34.99-32.75-32.42
Interest & Investment Income
21.944.766.7517.460.880.43
Currency Exchange Gain (Loss)
0.010.01--0.1-0.80.24
Other Non Operating Income (Expenses)
6.59-0.01-0.02-0.02-0.01-0.02
EBT Excluding Unusual Items
-242.31-569.82-804.18-812.94-643.39-333.59
Gain (Loss) on Sale of Investments
5.144.442.581.947.144.11
Gain (Loss) on Sale of Assets
-4.96-4.9-0.54-0-0-
Asset Writedown
-3.95-----0.43
Other Unusual Items
36.6534.624.869.6859.897.78
Pretax Income
-209.44-535.65-797.27-801.32-576.37-322.13
Net Income
-209.44-535.65-797.27-801.32-576.37-322.13
Net Income to Common
-209.44-535.65-797.27-801.32-576.37-322.13
Net Income Growth
------
Shares Outstanding (Basic)
332367367321274275
Shares Outstanding (Diluted)
332367367321274275
Shares Change
-9.38%-0.14%14.63%16.79%-0.32%-
EPS (Basic)
-0.63-1.46-2.17-2.50-2.10-1.17
EPS (Diluted)
-0.63-1.46-2.17-2.50-2.10-1.17
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-308.55-423.33-620.75-468.56-323.85-350.52
Free Cash Flow Per Share
-0.93-1.15-1.69-1.46-1.18-1.27
Gross Margin
85.08%92.81%80.32%119.44%-273.11%49.80%
Operating Margin
-30.71%-252.73%-2797.87%-65645.33%-128506.77%-770.14%
Profit Margin
-26.15%-232.16%-2649.19%-66142.68%-121278.86%-821.97%
Free Cash Flow Margin
-38.52%-183.48%-2062.65%-38675.98%-68143.75%-894.41%
EBITDA
-189.56-525.97-783.9-746.46-570.86-270.57
EBITDA Margin
-23.67%-227.96%----
D&A For EBITDA
56.457.1358.1248.8439.8631.26
EBIT
-245.96-583.11-842.02-795.29-610.72-301.82
EBIT Margin
-30.71%-252.73%----
Revenue as Reported
800.98230.7330.091.210.4839.19
Advertising Expenses
-1.82.340.35--